Approval · Notice of Compliance 10056 · 2009
NUVARING: Notice of Compliance 10056
Issued February 24, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10056
- Date
- February 24, 2009
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Contraceptive vaginal ring
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUVARING | 02253186 | Marketed |
Medicinal ingredients
- ETONOGESTREL 11.4 MG per RING
- ETHINYL ESTRADIOL 2.6 MG per RING